Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Spero Therapeutics Expects To Provide Phase 2a Topline Proof Of Concept Data From SPR720 Program; Co. Also Initiated Dosing In PIVOT-PO Phase 3 Trial And Is Entitled To Receive $95M In Milestones As Part Of License Agreement

Author: Benzinga Newsdesk | January 05, 2024 09:11am

Posted In: SPRO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist